Savings without changing: How to use the MyPKfit® device to improve treatment strategies in a cohort of patients with haemophilia A-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Savings without changing: How to use the MyPKfit® device to improve treatment strategies in a cohort of patients with haemophilia A

Published:2019-11 Issue: Volume:183 Page:1-3
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Pasca Samantha^ORCID,Zanon Ezio

Publisher

Elsevier BV

Subject

Hematology

Reference12 articles.

1. Current and emerging factor VIII replacement product for hemophilia A;Cafuir;Ther. Adv. Hematol.,2017

2. Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A;Young;J. Thromb. Haemost.,2015

3. Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A;Mahlangu;Blood,2014

4. Twenty-five years’ experience of prophylactic treatment in severe haemophilia A and B;Nilsson;J. Intern. Med.,1992

5. PK-driven prophylaxis versus standard prophylaxis: when a tailored treatment may be a real and achievable cost-saving approach in children with severe hemophilia A;Pasca;Thromb. Res.,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of FVIII pharmacokinetic profiles in Korean hemophilia A patients assessed with myPKFiT: a retrospective chart review;Blood Research;2024-08-28

2. “Getting the Dose Right”—Revisiting the Topic With Focus on Biologic Agents;Clinical Pharmacology & Therapeutics;2024-04-28

3. Blood-Induced Arthropathy: A Major Disabling Complication of Haemophilia;Journal of Clinical Medicine;2023-12-30

4. Pharmacokinetic-guided versus standard prophylaxis in hemophilia: a systematic review and meta-analysis;Journal of Thrombosis and Haemostasis;2023-12

5. The road to implementation of pharmacokinetic-guided dosing of factor replacement therapy in hemophilia and allied bleeding disorders. Identifying knowledge gaps by mapping barriers and facilitators;Blood Reviews;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3